Unfractionated Heparin Market Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017- 2025

Feb 2018| TMR177A| Transparency

Report Highlights

Global Unfractionated Heparin Market: Overview

This report on unfractionated heparin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing unfractionated heparin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global unfractionated heparin market with respect to the leading market segments based on major sources, distribution channels, and geographies.

Based on the source, the unfractionated heparin market has been segmented on the basis of source into: bovine source and porcine source. Based on the distribution Channel: it can be segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, technological advancement, and growing number of use of disposable products in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Unfractionated Heparin Market: Scope of the Report

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the unfractionated heparin market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global unfractionated heparin market.

Global Unfractionated Heparin Market: Segmentation

Geographically, unfractionated heparin market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global unfractionated heparin market.

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global unfractionated heparin market. The report also profiles key players operating in the unfractionated heparin market which includes Fresenius SE & Co. KGaA, Pfizer, Inc., LEO Pharma A/S, Baxter International Inc., B. Braun Melsungen AG, Sandoz International GmbH and Sagent Pharmaceuticals, Inc. among others.

The global unfractionated heparin market is segmented as follows:

Global Unfractionated Heparin Market, by Source

Bovine 
Porcine
Global Unfractionated Market, by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Unfractionated Heparin Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of the Europe
Asia Pacific
China
India
Japan
Australia
Indonesia
Malaysia
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
  • Table 2 : Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 3 : Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Region, 2015–2025
  • Table 4 : North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
  • Table 5 : North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 6 : North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 7 : Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
  • Table 8 : Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 9 : Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 10 : Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
  • Table 11 : Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 12 : Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 13 : Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
  • Table 14 : Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 15 : Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 16 : Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
  • Table 17 : Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 18 : Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country, 2015–2025
  • Table 19 : Fresenius SE & Co. KGaA Products Offering
  • Table 20 : Pfizer, Inc. products offering
  • Table 21 : Leo Pharma A/S products offering
  • Table 22 : Baxter International Inc. Products Offering
  • Table 23 : B.Braun Melsungen AG Products Offering
  • Table 24 : Sagent Pharmaceuticals, Inc. Products Offering
  • Table 25 : Mylan Inc. Products Offering
  • Figure 1 : Global Unfractionated Heparin Market Share (US$ Mn), by Distribution Channel, 2016
  • Figure 2 : Global Unfractionated Heparin Market Share (%), by Source, 2016
  • Figure 3 : Revenue Share, 2016
  • Figure 4 : Global Unfractionated Heparin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
  • Figure 5 : Market Value Share, by Source (2016)
  • Figure 6 : Market Value Share, by Distribution Channel (2016)
  • Figure 7 : Market Value Share, by Region (2016)
  • Figure 8 : Global Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
  • Figure 9 : Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bovine, 2015–2025
  • Figure 10 : Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porcine, 2015–2025
  • Figure 11 : Global Unfractionated Heparin Market Attractiveness, by Source
  • Figure 12 : Global Unfractionated Heparin Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 13 : Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2015–2025
  • Figure 14 : Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2015–2025
  • Figure 15 : Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2015–2025
  • Figure 16 : Global Unfractionated Heparin Market Attractiveness, by Distribution Channel
  • Figure 17 : Global Unfractionated Heparin Market Value Share, by Region, 2016 and 2025
  • Figure 18 : Global Unfractionated Heparin Market Attractiveness, by Region
  • Figure 19 : North America Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 20 : North America Unfractionated Heparin Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 21 : North America Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
  • Figure 22 : North America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 23 : North America Unfractionated Heparin Market Attractiveness Analysis, by Source, 2017–2025
  • Figure 24 : North America Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel, 2017–2025
  • Figure 25 : North America Unfractionated Heparin Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 26 : Europe Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 27 : Europe Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
  • Figure 28 : Europe Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
  • Figure 29 : Europe Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 30 : Europe Unfractionated Heparin Market Attractiveness Analysis, by Source
  • Figure 31 : Europe Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
  • Figure 32 : Europe Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 33 : Asia Pacific Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 34 : Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
  • Figure 35 : Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
  • Figure 36 : Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 37 : Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Source
  • Figure 38 : Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
  • Figure 39 : Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 40 : Latin America Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 41 : Latin America Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
  • Figure 42 : Latin America Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
  • Figure 43 : Latin America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 44 : Latin America Unfractionated Heparin Market Attractiveness Analysis, by Source
  • Figure 45 : Latin America Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
  • Figure 46 : Latin America Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 47 : Middle East & Africa Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 48 : Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Country
  • Figure 49 : Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
  • Figure 50 : Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 51 : Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Source
  • Figure 52 : Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
  • Figure 53 : Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 54 : Fresenius SE & Co. KGaA Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 55 : Fresenius SE & Co. KGaA R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
  • Figure 56 : Fresenius SE & Co. KGaA Breakdown of Net Sales, By Region 2016
  • Figure 57 : Fresenius SE & Co. KGaA Breakdown of Net Sales, by Segment, (overall company level), 2016
  • Figure 58 : Pfizer, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 59 : Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
  • Figure 60 : Pfizer, Inc. Breakdown of Net Sales, By Region 2016
  • Figure 61 : Pfizer, Inc. Breakdown of Net Sales, By Business Segments, 2017
  • Figure 62 : LEO Pharma A/S Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 63 : LEO Pharma A/S Breakdown of Net Sales, By Region, 2017
  • Figure 64 : LEO Pharma A/S Breakdown of Net Sales, By Business Segments, 2017
  • Figure 65 : Baxter International Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 66 : Baxter International Inc. R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
  • Figure 67 : Baxter International Inc. Breakdown of Net Sales, By Region 2016
  • Figure 68 : Baxter International Inc. Breakdown of Net Sales, (Overall Company Level), 2016
  • Figure 69 : B. Braun Melsungen AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 70 : B. Braun Melsungen AG R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
  • Figure 71 : B. Braun Melsungen AG Breakdown of Net Sales, By Region 2016
  • Figure 72 : B. Braun Melsungen AG Breakdown of Net Sales, (Overall Company Level), 2016
  • Figure 73 : Mylan Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 74 : Mylan Inc. R&D Intensity and Sales & Marketing Intensity (%) 2014–2016
  • Figure 75 : Mylan Inc. Breakdown of Net Sales, By Region, 2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report